Modern Rheumatology

Papers
(The TQCC of Modern Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD287
Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary publication48
Depression, physical function, and disease activity associated with frailty in patients with rheumatoid arthritis25
Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials24
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study23
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib21
Treatment strategies for elderly-onset rheumatoid arthritis in the new era20
Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study19
Clinical features of elderly-onset Adult-onset Still’s disease18
Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, random17
Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospec17
SAPHO syndrome and pustulotic arthro-osteitis15
Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a Phase II/III stu15
Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review14
Does exercise therapy improve patient-reported outcomes in rheumatoid arthritis? A systematic review and meta-analysis for the update of the 2020 JCR guidelines for the management of rheumatoid arthri14
Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches13
A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs13
Chronic postsurgical pain after total knee arthroplasty: A prospective cohort study in Japanese population13
Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit13
Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration13
Prevalence and clinical association with calcinosis cutis in early systemic sclerosis13
Annual variation rate of KL-6 for predicting acute exacerbation in patients with rheumatoid arthritis-associated interstitial lung disease12
Pool-based exercise for amelioration of pain in adults with fibromyalgia syndrome: A systematic review and meta-analysis12
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance12
Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis12
Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study12
Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the manageme12
Central sensitization in axial spondyloarthritis: An explorative study with quantitative sensory testing and clinical scales11
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?11
Recent advances in IgG4-related kidney disease11
Role of dietary patterns and factors in determining the risk of knee osteoarthritis: A meta-analysis11
Effects of brief self-exercise education on the management of chronic low back pain: A community-based, randomized, parallel-group pragmatic trial11
Pyroptosis inhibition alleviates potassium oxonate- and monosodium urate-induced gouty arthritis in mice11
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-w11
The impact of coexisting fibromyalgia syndrome on disease activity in patients with psoriatic arthritis and rheumatoid arthritis: A cross-sectional study10
COVID-19 in patients with Behçet’s disease: Outcomes and rate of Behçet’s exacerbations in a retrospective cohort10
The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE10
Glucocorticoids in the treatment of IgG4-related disease—Prospects for new international treatment guidelines10
Non-radiographic axial spondyloarthritis10
Potential of the prognostic nutritional index to determine the risk factor for severe infection in elderly patients with rheumatoid arthritis10
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome10
Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis10
Epidemiological study of osteonecrosis of the femoral head using the national registry of designated intractable diseases in Japan10
Macrophage activation syndrome in patients with adult-onset Still’s disease under tocilizumab treatment: A single-center observational study10
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial9
The involvement of leucine-rich α-2 glycoprotein in the progression of skin and lung fibrosis in bleomycin-induced systemic sclerosis model9
Rituximab in the real-world treatment of lupus nephritis: A retrospective cohort study in Japan9
Management of sarcopenia in patients with rheumatoid arthritis9
Ultrasound assessment of sarcopenia in patients with rheumatoid arthritis9
Distinct clinical characteristics of pediatric Behçet’s syndrome: A study from a referral center in China9
Trend in prescription and treatment retention of molecular-targeted drugs in 121,131 Japanese patients with rheumatoid arthritis: A population-based real-world study9
Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study9
The prevalence and impact of sarcopenia in females undergoing total hip arthroplasty: A prospective study9
The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study9
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine9
Efficacy and safety of avacopan in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: A subanalysis of a randomized Phase 3 study9
Interluekin-6 inhibitors for the treatment of adult-onset Still’s disease9
Questionnaire survey on transitional care for patients with juvenile idiopathic arthritis (JIA) and families9
Effective therapy of tocilizumab on systemic juvenile idiopathic arthritis–associated refractory macrophage activation syndrome9
Evaluation of the Central Sensitization Inventory Score in elderly adults with musculoskeletal examination9
The role of ultrasound and FDG-PET/CT to detect extracranial artery involvement in patients with suspected large vessel vasculitis9
Interferons and systemic lupus erythematosus: Pathogenesis, clinical features, and treatments in interferon-driven disease9
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid 9
Deep learning methods in the diagnosis of sacroiliitis from plain pelvic radiographs8
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort8
Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis8
The relationship between platelet to albumin ratio and disease activity in axial spondyloarthritis patients8
How should rheumatologists manage glucocorticoid-induced hyperglycemia?8
Long-term safety and effectiveness of mycophenolate mofetil in adults with lupus nephritis: a real-world study in Japan8
Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever8
Clinical features and prognosis of nocardiosis in patients with connective tissue diseases8
Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study8
Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis8
A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years8
Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort8
Validation of new ACR/EULAR 2022 classification criteria for anti-neutrophil cytoplasmic antibody–associated vasculitis8
Evaluation of retinal vascularization by optical coherence tomography angiography (OCTA) in rheumatoid arthritis, and its relationship with disease activity8
Differences of 2-year longitudinal changes of locomotive syndrome among patients treated with thoracolumbar interbody fusion, total hip arthroplasty, and total knee arthroplasty for degenerative disea7
Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Comm7
Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study7
Urticaria and increased risk of rheumatoid arthritis: a two-sample Mendelian randomisation study in European population7
MicroRNA-106b overexpression suppresses synovial inflammation and alleviates synovial damage in patients with rheumatoid arthritis7
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge study7
Automatic quantification and grading of hip bone marrow oedema in ankylosing spondylitis based on deep learning7
A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan7
Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics7
Relationship between locomotive syndrome and frailty in rheumatoid arthritis patients by locomotive syndrome stage7
Association between low back pain and quality of life in patients with rheumatoid arthritis according to patient-reported outcomes using the Japanese Orthopaedic Association Back Pain Evaluation Quest7
Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience7
Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids7
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication7
A multianalyte assay for the detection of dermatomyositis-related autoantibodies based on immunoprecipitation combined with immunoblotting7
JKAP serves as a potential biomarker for the evaluation of inflammatory condition, disease activity, and treatment response to TNF inhibitor in ankylosing spondylitis patients6
Foot orthosis treatment improves physical activity but not muscle quantity in patients with concurrent rheumatoid arthritis and sarcopenia6
Long-term outcome and predictors of remission in Behçet’s disease in daily practice6
Association between magnitude of femoral head collapse and quality of life in patients with osteonecrosis of the femoral head6
Efficacy of local oxygen–ozone therapy for the treatment of digital ulcer refractory to medical therapy in systemic sclerosis: A randomized controlled study6
Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis6
B-Cell depletion therapy in IgG4-related disease: State of the art and future perspectives6
Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study)6
Clinical features and outcomes of childhood polyarteritis nodosa: A single referral center experience6
Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis6
Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset6
Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database6
Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the managemen6
Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort6
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)6
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors6
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis6
Predictors of persistent inflammation in children with familial Mediterranean fever6
Perspectives on current and emerging therapies for immunoglobulin G4–related disease6
Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines6
Predictors of infliximab refractory intestinal Behçet’s syndrome: A retrospective cohort study from the Shanghai Behçet’s syndrome database5
Geographic distribution of the incidence of osteonecrosis of the femoral head in Japan and its relation to smoking prevalence5
Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population5
Pregnancy-associated risk factors and incidence of systemic sclerosis in primiparous women: A nationwide population-based cohort study5
MEFV E148Q variant is more associated with familial Mediterranean fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever5
Symptoms compatible with Rome IV functional bowel disorder in patients with ankylosing spondylitis5
The efficacy and safety of anifrolumab in Japanese patients with systemic lupus erythematosus: TULIP-2 subanalysis5
Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study5
Radiographic factors associated with painful callosities after forefoot surgery in patients with rheumatoid arthritis5
miR-144-3p aggravated cartilage injury in rheumatoid arthritis by regulating BMP2/PI3K/Akt axis5
Apremilast in a Japanese subgroup with Behçet’s syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study5
The implication of long non-coding RNA expression profile in rheumatoid arthritis: Correlation with treatment response to tumor necrosis factor inhibitor5
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study5
Two distinct subsets of LDGs (low density granulocytes) in ANCA-associated vasculitis5
Therapeutic effect of targeting Substance P on the progression of osteoarthritis5
Ultrasonography of IgG4-related dacryoadenitis and sialadenitis: Imaging features and clinical usefulness5
Have the radiographic characteristics of total knee arthroplasty recipients in rheumatoid arthritis changed after the induction of biologic disease modifying antirheumatic drugs?5
Improvement of locomotive syndrome after total hip arthroplasty: A two-year longitudinal cohort study5
Cost-effectiveness analyses of biologic and targeted synthetic disease-modifying anti-rheumatic diseases in patients with rheumatoid arthritis: Three approaches with a cohort simulation and real-world5
Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance5
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study5
Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study5
Effect of administration of immunoglobulin preparations on the results of tests for autoantibodies5
Minimum 10 years clinical results of an anatomical short stem with a proximal hydroxyapatite coating5
Extension contracture stiff knee in haemophilia: Surgical timing and procedure for total knee arthroplasty5
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort5
Drug efficacy and safety of biologics and Janus kinase inhibitors in elderly patients with rheumatoid arthritis5
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis5
Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study5
Is musculoskeletal pain related to locomotive syndrome even in young and middle-aged adults?5
Long-term safety and efficacy of E6011, an anti-fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to methotrexate5
High plasma homocysteine level is associated with increased prevalence of the non-remission state in rheumatoid arthritis: Findings from the KURAMA cohort5
Anti-Ro/SS-A antibody is associated with worse pulmonary outcome and reduced overall survival in systemic sclerosis5
Geographic variations in rheumatoid arthritis treatment in Japan: A nationwide retrospective study using the national database of health insurance claims and specific health checkups of Japan5
Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease5
Vitamin D receptor expression in SLE peripheral blood CD4+T cells is associated with disease activity and cell apoptosis4
Status of fracture risk assessment and osteoporosis treatment in Japanese patients with rheumatoid arthritis4
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study4
Similar short-term KOOS between open-wedge high tibial osteotomy and total knee arthroplasty in patients over age 60: A propensity score–matched cohort study4
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study4
Neck pain and related factors in patients with rheumatoid arthritis4
Comparison of physical activity levels among different sub-types of axial spondyloarthritis patients and healthy controls4
Simplified disease activity index and clinical disease activity index before and during pregnancy correlate with those at postpartum in patients with rheumatoid arthritis4
RS3PE syndrome: Autoinflammatory features of a rare disorder4
Differences in knee joint degeneration between primary hip osteoarthritis and hip osteoarthritis secondary to hip developmental dysplasia: A propensity score-based analysis4
Detection of nerve enlargement with ultrasound and correlation with skin biopsy findings in painful sensory neuropathy associated with Sjögren’s syndrome4
COVID-19 vaccination in patients with rheumatic diseases leads to a high seroconversion rate and reduced self-imposed isolation and shielding behaviour4
Prevalence and risk factors of monoclonal gammopathy in patients with autoimmune inflammatory rheumatic disease: A systematic review and meta-analysis4
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry4
Global research trends in hyperuricemia: a bibliometric and visualized study4
Hyperglobulinemia predicts increased risk of mortality in primary Sjögren’s syndrome: Based on a Chinese multicentre registry4
Evaluation of vitamin D profile in juvenile idiopathic arthritis4
Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography4
Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy – a study using dual-energy computed tomography4
Phenotypic landscape of systemic lupus erythematosus: An analysis of the Kyoto Lupus Cohort4
Updates on management strategies of hepatitis B virus reactivation in patients with resolved hepatitis virus B infection undergoing immunosuppressive therapy in rheumatology and the current situation 4
Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis4
What is the impact of methotrexate on liver in patients with juvenile idiopathic arthritis? Results of liver SWE performed in a single centre4
The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey4
Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management o4
Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis4
The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases4
A retrospective, longitudinal study of rheumatoid arthritis treatment patterns with Janus kinase inhibitors and other disease-modifying antirheumatic drugs in Japan4
Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospec4
Anti-ganglionic nicotinic acetylcholine receptor α3 subunit antibody as a potential biomarker associated with lupus enteritis4
Mast cells can produce transforming growth factor β1 and promote tissue fibrosis during the development of Sjögren’s syndrome-related sialadenitis4
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses4
Non-drug and surgical treatment algorithm and recommendations for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis—secondary4
Evaluation of quality and reliability of musculoskeletal ultrasound videos on YouTube4
Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study4
Proximal heat stress up-regulates angiopoietin-1 in fingers and reduces the severity of Raynaud’s phenomenon in systemic sclerosis: a single-centre pilot study4
Clinical features of paediatric immunoglobulin A vasculitis patients with scrotal involvement4
Central sensitisation in primary Sjögren Syndrome and its effect on sleep quality4
Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis4
High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study4
Clinical efficacy of alternative TNF inhibitor and secukinumab between primary non-responder and secondary non-responder of prior TNF inhibitor in ankylosing spondylitis4
Ultrasonography and contrast-enhanced ultrasound for activity assessment in 115 patients with carotid involvement of Takayasu arteritis4
Chest computed tomography findings of adult patients with antimelanoma differentiation-associated protein 5 antibody-positive interstitial lung disease4
Recent progress on the treatment of type 1 autoimmune pancreatitis and IgG4-related disease4
0.056526184082031